RVC will get 6 billion rubles for co-financing of drug development
The Russian government in several stages will contribute to the capital of the Russian venture company (RVC) 6 billion rubles for co-financing of risks of domestic companies on the development of innovative drugs and medical products. This was stated by Minister of industry and trade Denis Manturov during the governmental hour in the Federation Council, reports “Prime”.
We are talking about was created by the Ministry of industry and RVC venture capital Fund for high-tech medical projects. “The capital of the Fund is planned to Fund from 2019 to 2022 by 1.5 billion rubles,” — told in the press service of the Ministry. As noted earlier, the tenure of the mutual Fund is 10 years with possibility of extension.
“You know that to develop a chemical formula in the farm is high risk and not the fact that you will get the result. We, as an Agency, have not, unfortunately, the right to take such risks, so the decision was made by the government to contribute to the capital of RVC in the past 1.5 billion and $ 1.5 billion in subsequent years, in order to form a capital of 6 billion,” — said Manturov in the Scenarios.
He explained that this mechanism will motivate the private business to obtain new breakthrough innovative drugs and medical devices. According to him, is now with the Ministry of health the possibility to lay the guarantee of the state procurements of these medicines within the framework of national projects.
